MDP.TO MEDEXUS PHARMACEUTICALS INC
$5.08▲ +1.40%
Healthcare
Other
Volume 2.9K
Avg Volume (10D) 43.7K
Key Metrics & Fundamentals
Market Cap
$159.64M
P/E Ratio
–
Div Yield
–%
52W Range
2.51 - 5.50
% vs 50 MA
-1.72%
% vs 200 MA
32.82%
RSI-14
45.3
MACD Histogram
-0.0300
Beta (1Y vs SPY)
0.91
Free Cash Flow
-$11.22M
Gross Rev
$24.65M
Gross Profit
$13.27M
EBITDA
$4.11M
COGS
$11.38M
Operating Exp
$11.62M
Operating Income
$1.66M
EBIT
$1.66M
Pretax Income
-$3.01M
Net Income
-$2.68M
Price & Volume History
Loading chart…
Recent News
Medexus Pharmaceuticals Q1 Earnings Call Highlights
MarketBeat · Aug 12, 2026 3:04 AM
Medexus Pharmaceuticals Inc (MEDXF) (Q1 2027) Earnings Call Highlights: Graphopex Surges 118% ...
GuruFocus.com · Aug 11, 2026 7:00 PM
Medexus Pharmaceuticals Fiscal Q1 Net Income, Revenue Rise Year-on-Year
MT Newswires · Aug 11, 2026 11:57 AM
Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date
TMX Newsfile · Aug 10, 2026 9:30 PM
Medexus Schedules First Fiscal Quarter 2027 Conference Call
TMX Newsfile · Jul 30, 2026 9:30 PM
Medexus Pharmaceuticals Inc (MEDXF) Q4 2026 Earnings Call Highlights: Navigating Challenges and ...
GuruFocus.com · Jun 26, 2026 7:00 PM
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection
TMX Newsfile · Jun 25, 2026 10:00 PM
Micron Heads Into Earnings With Strong Signal
GuruFocus.com · Jun 22, 2026 12:57 PM
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
TMX Newsfile · Jun 16, 2026 9:30 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See MDP.TO's money flow as a full page
Social Sentiment
No Reddit posts found for MDP.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.